Aharon Schwartz, Director at Protalix BioTherapeutics, Inc. (PLX), bought 64,000 shares at $2.43 ($156K) on 2020-04-07, disclosed to the SEC on 2020-04-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| FOMX | BUY | 2018-12-06 | $438K | — | Filing → |